Furthermore, a recent study in the bleomycin-induced scleroderma mouse model demonstrated that inhibition of BAFF attenuates skin and lung fibrosis with reduction of IL-6–producing effector B cells [75]. This evidence concerns the gene TNFSF13B and pulmonary fibrosis.